Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non-small cell lung cancer.

Qian ZhaoButuo LiYiyue XuShijiang WangBing ZouJinming YuLinlin Wang

Published in: Cancer medicine (2021)

As mLIPI scores had the highest accuracy when used to predict the outcomes in Chinese aNSCLC patients, this tool could be used to guide clinical immunotherapy decision-making.

Keyphrases

advanced non small cell lung cancer
end stage renal disease
decision making
ejection fraction
newly diagnosed
epidermal growth factor receptor
chronic kidney disease
peritoneal dialysis
prognostic factors
metabolic syndrome
adipose tissue